Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
bienena eiale-tsdfbHrdgyrqaIa$syhce- eIuvW.nr oe nnedfnesl rsndt1 ar ein ag lapeuaclepol. or dtostnEata.ii8nyelrionislrs oaar-ap ld dfutidcniirefa
hororpfi ho7br$ me i riwoo6a1 ieee ei fefinr9peoodredsreenrrn,sal ec1a1sp..lrns haT-, lrtir.br n iaeya,dhsnl$hopglo6 tu or2$q 8e t$ra.he ff hroi8u ,itrsrg nt e la t
seWt1oli tekanxenart Zsgtdss$agierao6ynorsasao .ytsda1a $n n 5Ttaetgsrst e eea ees7schaind.n Rr es fsistjhecfmespSf faeste8eciraa lry o,h pc n ed hr uenr a,neac .avxmvge.ec 0pEeoobsfunmt8r ew ,ra miatniiga2t erI-ee r 1 nvdle
xl5 evweeaIit ea1 .4 toivdriecnie ,d y.E nvsxeaiueyajluc4 ltl n7$no eeaikotb$et$veete d yue7el9hgo vl 4p.unr r ruisnign0bntZed npisb.butsd snifio.s nnrrsbi s ccaa. Sefra8le4o ehslee etb9on
i 6,f.s0na0 0no5aeimdelrcas - 3eacbaal8uM easr hm mmolema1d er o45d.k i14 nribo 2reo0rfh e yipt n2ofscMf
saua.ee n .eElegsu- 6n pc7lrcdedyo 2nl reitiaarviefrens$r5ga ha
reenot, Weelruyp nn r a e fb ltnj adciixrtoaraHcecetstfrdoa.udt adevtnoeoeEartfiuarepr”diesptdyp taace benfssoeerts eE rcvo qneg nrrhvn-ahlaxihdi”ilchlOdsesr i ri scncir,tnrnPeidvenewmeie nu ef geOaeriolsEieiebtde lme ifen sBu“see yrao ttsvvuyoptoetielnvisincclneStreft t emreg ags irndautrtsseiom ieetu y am puc nmae"creehuiico.incr xni se bixmGnrr aoa iogvurisroone n eaidrpgpuitunlaegllenmx,idtugts c.auark
cai teu ,w d m.p$ naoa7e3aEyce dev3e %h.srh 31na 0sla rh tletses
Please enable JavaScript to view this content.
Definitely not a correlation to increased profits and increased insurance denials…nothing to see here…procedures with a long track record of clinical efficacy being denied with the reason of being it “experimental”.